StockData
PharmaCyte Biotech, Inc. logo

PharmaCyte Biotech, Inc. (PMCB) stock

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$5.37−0.05 (-0.92%)

Close on Nov 18, 2026Market cap $57.65MP/E –Yield –

PharmaCyte Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

PharmaCyte Biotech's pe ratio was 0.3× on May 29, 2026, against 1.3× a year earlier. Over the last 2 years it ranged from 0.2× to 47.2×, with a median of 1.3×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026May 29, 20260.3×+0.1
2025Dec 31, 20250.2×−2.6
2024Dec 31, 20242.8×–

More PharmaCyte Biotech figures

See a number that looks wrong?